The AIDS and HIV epidemic once captured global attention, proliferating from a single case in 1981 to the nation’s leading ...
In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...
Kenya's Ministry of Health said on Saturday that it has approved the rollout of lenacapavir, a twice-yearly HIV prevention Kenya breaking news | Kenya news today | ...
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
Learn about the medical advancements and challenges faced by older adults living with HIV. Experts and survivors share their insights.
WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...
The US government paused all foreign assistance in January 2025. This abrupt decision affected the delivery of life-saving ...
Two former U.S. Agency for International Development (USAID) workers have started a new volunteer group called Crisis in Care ...
The Star Worldwide (English) on MSN
Kenya recommends registration of long-acting HIV prevention drug Lenacapavir
Kenya is now among the first African countries to recommend Lenacapavir for registration, a move the Ministry said aligns ...
The Kenya Times on MSN
Kenya to introduce long-acting HIV prevention drug in landmark move
Kenya has taken a major step towards expanding HIV prevention options after the Ministry of Health formally recommended the ...
Dr Robert Mutumba, the head of the Aids Control Programme at the Ministry of Health, told Daily Monitor that Ugandans are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback